Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations KR McSweeney, LK Gadanec, T Qaradakhi, BA Ali, A Zulli, ... Cancers 13 (7), 1572, 2021 | 277 | 2021 |
Can SARS-CoV-2 virus use multiple receptors to enter host cells? LK Gadanec, KR McSweeney, T Qaradakhi, B Ali, A Zulli, ... International journal of molecular sciences 22 (3), 992, 2021 | 163 | 2021 |
The anti-inflammatory effect of taurine on cardiovascular disease T Qaradakhi, LK Gadanec, KR McSweeney, JR Abraham, ... Nutrients 12 (9), 2847, 2020 | 126 | 2020 |
The potential actions of angiotensin‐converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases T Qaradakhi, LK Gadanec, KR McSweeney, A Tacey, V Apostolopoulos, ... Clinical and Experimental Pharmacology and Physiology 47 (5), 751-758, 2020 | 96 | 2020 |
Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: A proposed approach to SARS-CoV-2 treatment L Kate Gadanec, T Qaradakhi, K Renee McSweeney, B Ashiana Ali, ... Future Microbiology 16 (4), 205-209, 2021 | 30 | 2021 |
Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels LK Gadanec, T Qaradakhi, KR McSweeney, JM Matsoukas, ... Biochemical Pharmacology 208, 115397, 2023 | 13 | 2023 |
Imipridone enhances vascular relaxation via FOXO1 pathway KR McSweeney, LK Gadanec, T Qaradakhi, TM Gammune, P Kubatka, ... Clinical and Experimental Pharmacology and Physiology 47 (11), 1816-1823, 2020 | 5 | 2020 |
Angiotensin II constricts mouse iliac arteries: Possible mechanism for aortic aneurysms LK Gadanec, KR McSweeney, P Kubatka, M Caprnda, L Gaspar, ... Molecular and cellular biochemistry 479 (2), 233-242, 2024 | 3 | 2024 |
Cisplatin treatment reduces contraction to angiotensin II by altering expression of angiotensin II receptors: a pilot study KR McSweeney, LK Gadanec, P Kubatka, M Caprnda, L Gaspar, ... Molecular and Cellular Biochemistry 478 (12), 2907-2916, 2023 | | 2023 |